Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuma Ito

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Biological & Pharmaceutical Bulletin|October 1, 2023
Osteogenic Effects of KY-054, a Novel Coumarin Derivative on Femur Cortical Bone in Ovariectomized Female RatsMegumi Yamamoto, Yuma Ito, Masaki Fukui, et al.
Journal of Pharmacological Sciences|May 8, 2018
Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in miceYuma Ito, Masaki Fukui, Mamoru Kanda, et al.
Chemical & Pharmaceutical Bulletin|December 4, 2018
2-Acyl-3-carboxyl-tetrahydroisoquinoline Derivatives: Mixed-Type PTP1B Inhibitors without PPARγ ActivationKo Morishita, Yoshimichi Shoji, Masaki Fukui, et al.
Biological & Pharmaceutical Bulletin|March 20, 2024
Osteoblastgenic and Osteogenic Effects of KY-273 with CDK8/19 Inhibitory Activity in Bone Marrow Mesenchymal Stem Cells and Female RatsMegumi Yamamoto, Yui Shibata, Yuma Ito, et al.
International Journal of Surgical Pathology|March 9, 2023
Rectal Carcinoma With a Sarcomatoid Component: A Case Report With Detailed Immunohistochemistry, Molecular Analysis, and Literature ReviewMikiya Todori, Naoki Yanagawa, Kazuhiro Ito, et al.
Chemical & Pharmaceutical Bulletin|November 6, 2019
(S)-1,2,3,4-Tetrahydroisoquinoline Derivatives Substituted with an Acidic Group at the 6-Position as a Selective Peroxisome Proliferator-Activated Receptor γ Partial AgonistKo Morishita, Tomohiro Miike, Shigemitsu Takeda, et al.
Chemical & Pharmaceutical Bulletin|December 5, 2017
Novel Non-carboxylate Benzoylsulfonamide-Based Protein Tyrosine Phosphatase 1B Inhibitors with Non-competitive ActionsKo Morishita, Yoshimichi Shoji, Shunkichi Tanaka, et al.
Chemical & Pharmaceutical Bulletin|April 1, 2021
Synthesis and Evaluation of a Novel Series of 2,7-Substituted-6-tetrazolyl-1,2,3,4-tetrahydroisoquinoline Derivatives as Selective Peroxisome Proliferator-Activated Receptor γ Partial AgonistsKo Morishita, Yuma Ito, Kazuya Otake, et al.
Journal of Biochemistry|December 23, 2016
Conformational changes in inhibitory PAS domain protein associated with binding of HIF-1α and Bcl-xL in living cellsShuya Kasai, Shinji Kajimoto, Yuma Ito, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|August 31, 2021
Visualizing looping of two endogenous genomic loci using synthetic zinc-finger proteins with anti-FLAG and anti-HA frankenbodies in living cellsYang Liu, Ning Zhao, Masato T Kanemaki, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Biological & Pharmaceutical Bulletin|October 1, 2023
Osteogenic Effects of KY-054, a Novel Coumarin Derivative on Femur Cortical Bone in Ovariectomized Female RatsMegumi Yamamoto, Yuma Ito, Masaki Fukui, et al.
Journal of Pharmacological Sciences|May 8, 2018
Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in miceYuma Ito, Masaki Fukui, Mamoru Kanda, et al.
Chemical & Pharmaceutical Bulletin|December 4, 2018
2-Acyl-3-carboxyl-tetrahydroisoquinoline Derivatives: Mixed-Type PTP1B Inhibitors without PPARγ ActivationKo Morishita, Yoshimichi Shoji, Masaki Fukui, et al.
Biological & Pharmaceutical Bulletin|March 20, 2024
Osteoblastgenic and Osteogenic Effects of KY-273 with CDK8/19 Inhibitory Activity in Bone Marrow Mesenchymal Stem Cells and Female RatsMegumi Yamamoto, Yui Shibata, Yuma Ito, et al.
International Journal of Surgical Pathology|March 9, 2023
Rectal Carcinoma With a Sarcomatoid Component: A Case Report With Detailed Immunohistochemistry, Molecular Analysis, and Literature ReviewMikiya Todori, Naoki Yanagawa, Kazuhiro Ito, et al.
Chemical & Pharmaceutical Bulletin|November 6, 2019
(S)-1,2,3,4-Tetrahydroisoquinoline Derivatives Substituted with an Acidic Group at the 6-Position as a Selective Peroxisome Proliferator-Activated Receptor γ Partial AgonistKo Morishita, Tomohiro Miike, Shigemitsu Takeda, et al.
Chemical & Pharmaceutical Bulletin|December 5, 2017
Novel Non-carboxylate Benzoylsulfonamide-Based Protein Tyrosine Phosphatase 1B Inhibitors with Non-competitive ActionsKo Morishita, Yoshimichi Shoji, Shunkichi Tanaka, et al.
Chemical & Pharmaceutical Bulletin|April 1, 2021
Synthesis and Evaluation of a Novel Series of 2,7-Substituted-6-tetrazolyl-1,2,3,4-tetrahydroisoquinoline Derivatives as Selective Peroxisome Proliferator-Activated Receptor γ Partial AgonistsKo Morishita, Yuma Ito, Kazuya Otake, et al.
Journal of Biochemistry|December 23, 2016
Conformational changes in inhibitory PAS domain protein associated with binding of HIF-1α and Bcl-xL in living cellsShuya Kasai, Shinji Kajimoto, Yuma Ito, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|August 31, 2021
Visualizing looping of two endogenous genomic loci using synthetic zinc-finger proteins with anti-FLAG and anti-HA frankenbodies in living cellsYang Liu, Ning Zhao, Masato T Kanemaki, et al.
Pageof 4